HUP0002231A2 - Porc oligomer mátrix fehérje alkalmazása reumatoid arthritis kezelésére - Google Patents

Porc oligomer mátrix fehérje alkalmazása reumatoid arthritis kezelésére

Info

Publication number
HUP0002231A2
HUP0002231A2 HU0002231A HUP0002231A HUP0002231A2 HU P0002231 A2 HUP0002231 A2 HU P0002231A2 HU 0002231 A HU0002231 A HU 0002231A HU P0002231 A HUP0002231 A HU P0002231A HU P0002231 A2 HUP0002231 A2 HU P0002231A2
Authority
HU
Hungary
Prior art keywords
treatment
matrix protein
fragments
oligomeric matrix
cartilage oligomeric
Prior art date
Application number
HU0002231A
Other languages
English (en)
Inventor
Dick Heinegárd
Lars Klareskog
Johnny C. Lorentzen
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of HUP0002231A2 publication Critical patent/HUP0002231A2/hu
Publication of HUP0002231A3 publication Critical patent/HUP0002231A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A találmány tárgyát porc oligomer mátrix fehérjének (COMP) vagyfragmentumainak vagy analógjainak emlősök izületi gyulladásosállapotainak (arthritis) megelőzésére vagy kezelésére szolgálógyógyszerkészítmény előállítására történő alkalmazása képezi. Agyógyszerkészítmény COMP-ot vagy fragmentumait vagy analógjait azízületi gyulladásos állapot megelőzéséhez vagy tüneteinek enyhítéséhezhatásos mennyiségben tartalmazza. Egy másik alkalmazási lehetőség,amikor a gyógyszerkészítmény COMP vagy fragmentumai vagy analógjaikifejezésére képes RNS- vagy DNS-szekvenciákat tartalmaz. Ó
HU0002231A 1997-04-15 1998-04-14 Use of cartilage oligomeric matrix protein for the treatment of rheumatoid arthritis HUP0002231A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9701409A SE9701409D0 (sv) 1997-04-15 1997-04-15 Treatment of rheumatoid arthritis

Publications (2)

Publication Number Publication Date
HUP0002231A2 true HUP0002231A2 (hu) 2000-11-28
HUP0002231A3 HUP0002231A3 (en) 2002-09-30

Family

ID=20406587

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002231A HUP0002231A3 (en) 1997-04-15 1998-04-14 Use of cartilage oligomeric matrix protein for the treatment of rheumatoid arthritis

Country Status (21)

Country Link
EP (1) EP1019078B1 (hu)
JP (1) JP2001520647A (hu)
KR (1) KR20010006352A (hu)
CN (1) CN1260721A (hu)
AT (1) ATE245438T1 (hu)
AU (1) AU746221B2 (hu)
BR (1) BR9808591A (hu)
CA (1) CA2286791A1 (hu)
DE (1) DE69816634T2 (hu)
EE (1) EE9900464A (hu)
HU (1) HUP0002231A3 (hu)
ID (1) ID24561A (hu)
IL (1) IL132354A0 (hu)
IS (1) IS5210A (hu)
NO (1) NO995004D0 (hu)
NZ (1) NZ338084A (hu)
PL (1) PL336163A1 (hu)
SE (1) SE9701409D0 (hu)
SK (1) SK141399A3 (hu)
TR (1) TR199902564T2 (hu)
WO (1) WO1998046253A1 (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6849594B1 (en) * 1999-06-30 2005-02-01 John Lawler Purification and use of human recombinant cartilage oligomeric matrix protein
SE9904236D0 (sv) 1999-11-22 1999-11-22 Ana Mar Diagnostics Ab Immunoassay
KR100429288B1 (ko) * 2001-11-23 2004-04-29 장오기계 주식회사 전사인쇄장치
CN100417415C (zh) * 2006-06-28 2008-09-10 文彦春 浸润治疗关节炎的药物
WO2014003679A1 (en) 2012-06-28 2014-01-03 Anamar Ab Determining pathological cartilage turnover

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192744A (en) * 1990-01-12 1993-03-09 Northwestern University Method of inhibiting angiogenesis of tumors
US5872094A (en) * 1993-01-06 1999-02-16 The General Hospital Corporation Method for attaching cartilaginous tissue, cartilage matrix protein or link protein to a surface

Also Published As

Publication number Publication date
NO995004L (no) 1999-10-14
SE9701409D0 (sv) 1997-04-15
EE9900464A (et) 2000-04-17
SK141399A3 (en) 2000-08-14
BR9808591A (pt) 2000-05-23
ID24561A (id) 2000-07-27
WO1998046253A1 (en) 1998-10-22
ATE245438T1 (de) 2003-08-15
DE69816634T2 (de) 2004-06-03
NZ338084A (en) 2001-07-27
IS5210A (is) 1999-10-12
EP1019078B1 (en) 2003-07-23
CN1260721A (zh) 2000-07-19
AU746221B2 (en) 2002-04-18
KR20010006352A (ko) 2001-01-26
HUP0002231A3 (en) 2002-09-30
JP2001520647A (ja) 2001-10-30
PL336163A1 (en) 2000-06-05
CA2286791A1 (en) 1998-10-22
EP1019078A1 (en) 2000-07-19
IL132354A0 (en) 2001-03-19
DE69816634D1 (de) 2003-08-28
NO995004D0 (no) 1999-10-14
TR199902564T2 (xx) 2000-02-21
AU7093898A (en) 1998-11-11

Similar Documents

Publication Publication Date Title
NO20006716L (no) Proteaseinhibitorer
BR9913878A (pt) Sintases
GEP20033002B (en) Osteoprotegerin Binding Protein and Receptors
BR9712402A (pt) Novas toxinas pesticidas e sequencias de nucleotídeos que codificam essas toxina
IL135687A0 (en) A novel human checkpoint kinase, hcds1, compositions and methods
HUP0002231A2 (hu) Porc oligomer mátrix fehérje alkalmazása reumatoid arthritis kezelésére
DE69736276D1 (de) Menschliche dnase resistent gegen actininhibitoren
EP1448587A4 (en) NOONANSYNDROMGEN
WO1997044454A3 (en) Human phospholipase inhibitor
BR0114977A (pt) segmentos preferidos de proteìna de filamento neural e métodos para uso dos mesmos
PT640098E (pt) Gene de coronavirus canino e suas utilizacoesc
EP1885750A4 (en) MORPHOGENETIC PROTEIN OF OS 4 AND OSTEOGENIC DEVICES AND PHARMACEUTICAL PRODUCTS CONTAINING SAME
HUP0300787A2 (hu) Új interferon a sclerosis multiplex kezelésére
BRPI0412477A (pt) aperfeiçoados polipeptìdeos de interferon-beta-1b recombinantes humanos
FR2792651A1 (fr) Sequence genomique et polypeptides de pyrococcus abyssi, leurs fragments et leurs utilisations
HUP0004739A1 (hu) Presenilinekkel kölcsönhatásra képes fehérjéket kódoló nukleinsavak
WO1995003333A3 (en) Tryptase inhibitor
BR9408077A (pt) Enzimas de conversão de endotelina seqências de dna, processos para a obtenção por técnicas genéticas, de enzimas de conversão de endotelina substâncias inhibidoras para enzimas de conversão de endotelina e para a prepação de medicamentos que inibem uma enzima de conversão de endotelina e aplicações da enzima de conversão de endotelina das substâncias inibidoras de anticorpos de uma sequência de dna e de sequências parciais
DE69529235T2 (de) Menschliche dnase i varianten
AU2001287860A1 (en) Transglutaminase gene products
HUP0203689A2 (hu) Interleukin-1 receptor antagonistaszerű molekulák és ezek használata
WO2001055209A3 (en) Novel human septin and uses thereof
WO2004011638A3 (en) Deoxyuridine 5' triphosphate nucleotidohydrolase polypeptides and structures
PT92552A (pt) Processo de producao de sequencias de adn que codificam proteinas inibidoras da serina-protease, e de producao daquelas proteinas, de medicamentos que as contem e de vectores de expressao contendo as sequencias de adn
WO2002029023A8 (en) Nicastrin protein